Medios AG/€ILM1
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Medios AG
Medios AG, headquartered in Berlin, Germany, specializes in the supply and manufacturing of specialty pharmaceutical products, focusing on treatments for chronic and rare diseases. The company operates through two primary segments: Pharmaceutical Supply, offering a portfolio of approximately 1,000 specialty pharma drugs across therapeutic areas such as oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia; and Patient-Specific Therapies, producing individualized medications, including cytostatic infusions, antibody therapies, virostatic and antibiotic medications, and parenteral nutrition solutions, with around 400,000 preparations completed in fiscal year 2023. Founded in 2016, Medios AG has expanded its geographic footprint to include operations in Germany, the Netherlands, Belgium, and Spain. The company's strategic positioning emphasizes individualized medicine, collaborating with pharmacies, specialist practices, and pharmaceutical companies to make innovative therapies widely accessible.
Ticker
€ILM1
Sector
Primary listing
XETRA
Employees
1,006
Headquarters
Website
Medios AG Metrics
BasicAdvanced
€367M
19.54
€0.74
1.17
-
Price and volume
Market cap
€367M
Beta
1.17
52-week high
€17.50
52-week low
€9.98
Average daily volume
20K
Financial strength
Current ratio
1.922
Quick ratio
1.358
Long term debt to equity
33.182
Total debt to equity
38.93
Interest coverage (TTM)
3.18%
Profitability
EBITDA (TTM)
74.095
Gross margin (TTM)
9.66%
Net profit margin (TTM)
0.96%
Operating margin (TTM)
2.18%
Effective tax rate (TTM)
36.72%
Revenue per employee (TTM)
€1,960,000
Management effectiveness
Return on assets (TTM)
2.90%
Return on equity (TTM)
3.67%
Valuation
Price to earnings (TTM)
19.54
Price to revenue (TTM)
0.187
Price to book
0.7
Price to tangible book (TTM)
13.85
Price to free cash flow (TTM)
6.616
Free cash flow yield (TTM)
15.12%
Free cash flow per share (TTM)
2.18
Growth
Revenue change (TTM)
7.02%
Earnings per share change (TTM)
10.68%
3-year revenue growth (CAGR)
9.08%
3-year earnings per share growth (CAGR)
13.50%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medios AG stock?
Medios AG (ILM1) has a market cap of €367M as of August 24, 2025.
What is the P/E ratio for Medios AG stock?
The price to earnings (P/E) ratio for Medios AG (ILM1) stock is 19.54 as of August 24, 2025.
Does Medios AG stock pay dividends?
No, Medios AG (ILM1) stock does not pay dividends to its shareholders as of August 24, 2025.
When is the next Medios AG dividend payment date?
Medios AG (ILM1) stock does not pay dividends to its shareholders.
What is the beta indicator for Medios AG?
Medios AG (ILM1) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.